Meetings of the Pediatric Ethics Subcommittee
2008
- On June 9, 2008, the Pediatric Ethics Subcommittee of the Pediatric Advisory Committee will meet to discuss the application of 21 CFR 50.52 (Clinical investigations involving greater than minimal risk but presenting the prospect of direct benefit to individual subjects) to FDA-regulated research. The discussion will be illustrated with hypothetical case examples of research involving HIV vaccines in adolescents and controlled trials of inhaled corticosteroids in children with asthma. On June 10, 2008, the Subcommittee will meet to discuss the application of 21 CFR 50.52 to FDA-regulated research illustrated with a hypothetical case example of research using stem cells for treating periventricular white matter injury in children.
Complete FR Notice attached below:
Meeting on June 9, 2008 and June 10, 2008
OC 200879. Pediatric Ethics Subcommittee of the Pediatric Advisory Committee;
Notice of Meeting. Page 21145 [FR Doc. E8-8352] [TXT] [PDF] [PRE-PUB]
2005
2004
